What do they do?
Realbotix Corp. (formerly Tokens.com) is a humanoid robotics and AI company that designs and manufactures "socially intelligent" robots. Unlike industrial robots built for heavy lifting, Realbotix focuses on human-centric interaction. Their robots are designed for:
- Commercial Use: Social greeters, brand ambassadors, and customer service agents in retail (e.g., Times Square), hospitality, and healthcare
- Personal Use: Companionship and entertainment through highly realistic, customizable humanoid figures
- Physical AI: Proprietary software that enables robots to have unscripted, autonomous conversations and recognize human emotions through a patented vision system
What is their best product?
Their flagship product is Aria, an AI-powered humanoid robot.
Why: Aria is the company's "AI Ambassador." In 2025 and 2026, Aria became the first humanoid to host a podcast and has been deployed in high-profile locations like the Fashion Show Mall in Las Vegas. It features 39 degrees of freedom in its upper body and a patented vision system that allows it to "see" colors, read text, and interpret emotional cues.
Do they have a competitive advantage?
Yes, in "Hyper-Realism" and "AI-Agnosticism."
- Extreme Customization: While competitors like Tesla offer a single "Optimus" design, Realbotix can recreate specific human faces, celebrities, or historical figures
- AI-Agnostic Architecture: Their hardware can run on any Large Language Model (LLM), allowing customers to plug in their own proprietary AI or specialized companionship software
- Immediate Availability: Unlike many "vaporware" robotics startups, Realbotix is currently shipping units, with lower-cost robotic "busts" starting under $10,000
Does this company have the potential to change the world?
Yes, by addressing the "Loneliness Epidemic" and Labor Shortages.
Realbotix is pioneering the use of robots in senior care and therapy, where emotional connection is more important than physical strength. If successful, they could become the primary provider of the "human interface" for AI, moving it from a screen into the physical world.
Who is their biggest competitor?
Realbotix operates in a unique niche, but they face competition from:
- Social/Companion Robotics: Miko (companion/educational) and Intuition Robotics (elderly care)
- Humanoid Giants: Tesla (Optimus), Figure AI, and Apptronik (though these focus more on industrial tasks)
- Service Robotics: Softbank Robotics (Pepper/Nao) and UBTECH
Leadership
| Name | Title | Education |
|---|---|---|
| Andrew Kiguel | Co-Founder & CEO | York University (BA); Former investment banker (Stifel/GMP) |
| Scott Meyers | CFO (Appointed 2026) | Michigan State University (CPA) |
| Matt Kimes | CTO | Specialist in Physical AI and Animatronics |
Financial Health (March 2026)
- Revenue Growth: 2025 revenue grew 121% to $2.0 million, following the pivot from crypto-assets to robotics
- Balance Sheet: The company is currently debt-free and holds approximately $8.6 million (CAD$11.8M) in cash as of March 2026
- Cash Burn: Currently burning ~$425k per month, giving them more than 12 months of runway at current levels
- Recent News: In February 2026, the company announced it would sell its Realbotix LLC subsidiary to Onconetix (NASDAQ: ONCO) in an all-stock deal, intended to move the robotics business to a senior U.S. exchange (NASDAQ)
Valuation
- Market Cap: ~$59 million (as of March 6, 2026)
- Status: Considered a Micro-cap/Penny Stock
- Outlook: The valuation is currently tied to the successful closing of the Onconetix merger (expected Q3 2026) and the company's ability to scale manufacturing from dozens of units to 1,000+ units by 2027
Final Verdict
SPECULATIVE BUY / WATCHLIST
Realbotix is a high-risk, high-reward "pure play" in humanoid robotics. They have a massive head start in the aesthetic and social side of robotics. However, investors should be cautious of the current Management Cease Trade Order (MCTO) related to filing delays and the inherent volatility of OTC-traded stocks. The move to NASDAQ via the Onconetix deal is the critical catalyst to watch.